Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study
Ophthalmology (Rochester, Minn.), 2010-06, Vol.117 (6), p.1124 [Peer Reviewed Journal]Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. ;EISSN: 1549-4713 ;DOI: 10.1016/j.ophtha.2010.02.022 ;PMID: 20381871
Digital Resources/Online E-Resources